Market Access, Value, and Reimbursement Resources
With payer pressure rising and regulatory structures growing more complex, it’s no surprise that life sciences companies are trying to formalize the way they address market access, value, and reimbursement challenges. Develop comprehensive strategies with help from this expert resource library and our highly skilled, on-demand consultants.
-
The Lasting Impact of COVID-19 on U.S. Pharma Marketing
How can pharma marketers remain effective and relevant for key customers, patients, and healthcare providers (HCPs) in the time of COVID-19?
-
Find the perfect market access consultant.
Start a Project -
Life Science Lens: On-Demand Talent for Resilience and Agility
On-demand talent is a critical resource for life science and pharma companies as they innovate to keep pace with market changes, respond to emerging health threats, and adapt to a remote environment.
-
A Rare Disease Specialist Fluent in the Project Location’s Language
In an effort to inform its Rare Diseases commercial strategy within a specific country, an F100 pharmaceutical company was looking to gain a deeper understanding of the current competitive...
-
Innovations in Market Access Consulting: How On-Demand Talent Can Help
It’s not easy to bring a new drug to market. As corporate market access functions evolve to help life science companies streamline the complex process of getting therapies into patients’ hands,...
-
On-Demand Talent for Innovation, Transformation, and Growth in Life Sciences
Independent talent provide an agile source of critical skills that allow life science leaders to keep pace in a fast-changing environment.
-
How has 2020 volatility impacted the work of independent talent?
Get the Report -
Project Management Lead for Medical Evidence, Research, and Innovation Team
An F500 biotech company wanted to engage a consultant to work with its medical evidence, research, and innovation team to create and coordinate several projects related to the generation of...
-
Developing Compelling Global Health Policy Narratives and Supporting Evidence
As a part of its global therapeutic area (TA) health policy initiatives, a leading biopharma company needed a new and improved narrative and evidence deck to impress upon policymakers and other...
-
See our market access capabilities and more.
Read More -
Managing Patient / HCP Promotions Process in Biopharma
The U.S. patient access team at an F200 biopharma leader was seeking a strong project manager who would support their market access and marketing teams with patient / HCPs promotions. The client...
-
BTG Key Strengths: Market Access, Value & Reimbursement
Get expert advice and seasoned project managers for all your market access, value, and reimbursement initiatives.
-
Remote Consulting Jobs: How Top Companies Are Getting Critical Work Done from a Distance
Remote work has suddenly become the new normal for independent consultants. Here are the types of work best suited for remote consulting jobs.
-
Early Pipeline Market Access Evaluations
In the midst of a company-wide reorganization, the Cell Therapy Market Access team at an F200 pharmaceutical company needed a value and access expert to support several projects. Looking for...
-
What Does Payer/Provider Consolidation Mean For the Future of Pharma?
The lines are blurring between U.S. healthcare payers and providers. What does this payer/provider consolidation mean for pharma? Nothing less than a total shift in the way it does business. If...
-
How can independent talent help you?
Let's Talk -
Business Talent Group Key Strengths: Life Sciences
Innovation is at the heart of the life sciences industry. BTG has the hands and minds you need to make it happen.
-
Business Talent Group Releases 2018 Skills Index
Data from independent consulting marketplace Business Talent Group provides compelling snapshot of growing needs—and how freelance consultants are filling skill and knowledge gaps.
-
Market Access Sales Training and Support
The pharmaceutical reimbursement landscape has grown increasingly complex and—thanks to an intensifying focus on improving clinical outcomes—increasingly competitive. Reimbursement was once a...
-
Prescription Drug Affordability: A Q&A With Asif Velani and Will Wright
Prescription drug affordability is a major concern in health and life science. Asif Velani and Will Wright talk about how to address it.
-
Pricing and Tender Strategy
The head of the medical products division at a F200 healthcare company was concerned about stagnating profits in the U.S. She had identified 15 different countries that presented growth...
-
Business Talent Group Skills Index 2018
The world’s top companies are increasingly relying on high-end freelance talent for mission-critical projects. The BTG Skills Index ranks the most requested and fastest growing consulting skills.
-
Market Access Innovations: Pharmaceutical Affordability
Affordability is a major concern in health and life science—and not just in the U.S. In 2018, total prescription drug expenditure in the U.S. is expected to top $520 billion; 52% of Americans say...
-
Accelerating an Oncology Drug Launch
A F300 pharma company was preparing to launch a new oncology drug. But its understaffed pricing and market access group was struggling to create global access plans and strategies. Expecting...
-
Loading More...